MATTHEW CHOUINARD: Open Payments
NPI 1790474237 · PORTSMOUTH, NH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$575 in 19 payments from 7 companies in 2025. Trend: 2023 $157 · 2024 $999 · 2025 $575
Food & beverage: $575
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 10 | $221 |
| Inspire Medical Systems, Inc. | 1 | $149 |
| Regeneron Healthcare Solutions, Inc. | 4 | $81 |
| BioCryst US Sales Co., LLC | 1 | $46 |
| Blueprint Medicines Corporation | 1 | $32 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $29 |
| GlaxoSmithKline, LLC. | 1 | $17 |
Products named: DUPIXENT, INSPIRE, ORLADEYO, AYVAKIT, NEFFY, NUCALA.
Industry payments across NH — which companies pay providers there.
